138 related articles for article (PubMed ID: 8567558)
1. Secretory leukoprotease inhibitor attenuates lung injury induced by continuous air embolization into sheep.
Gossage JR; Perkett EA; Davidson JM; Starcher BC; Carmichael D; Brigham KL; Meyrick B
J Appl Physiol (1985); 1995 Oct; 79(4):1163-72. PubMed ID: 8567558
[TBL] [Abstract][Full Text] [Related]
2. Sequence of structural changes and elastin peptide release during vascular remodelling in sheep with chronic pulmonary hypertension induced by air embolization.
Perkett EA; Davidson JM; Meyrick B
Am J Pathol; 1991 Dec; 139(6):1319-32. PubMed ID: 1836307
[TBL] [Abstract][Full Text] [Related]
3. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma.
Wright CD; Havill AM; Middleton SC; Kashem MA; Lee PA; Dripps DJ; O'Riordan TG; Bevilacqua MP; Abraham WM
J Pharmacol Exp Ther; 1999 May; 289(2):1007-14. PubMed ID: 10215681
[TBL] [Abstract][Full Text] [Related]
4. Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense.
Birrer P; McElvaney NG; Gillissen A; Hoyt RF; Bloedow DC; Hubbard RC; Crystal RG
J Appl Physiol (1985); 1992 Jul; 73(1):317-23. PubMed ID: 1354669
[TBL] [Abstract][Full Text] [Related]
5. Secretory leukocyte protease inhibitor, but not alpha-1 protease inhibitor, blocks tryptase-induced bronchoconstriction.
Forteza RM; Ahmed A; Lee T; Abraham WM
Pulm Pharmacol Ther; 2001; 14(2):107-10. PubMed ID: 11273791
[TBL] [Abstract][Full Text] [Related]
6. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
[TBL] [Abstract][Full Text] [Related]
7. Continuous air embolization into sheep causes sustained pulmonary hypertension and increased pulmonary vasoreactivity.
Perkett EA; Brigham KL; Meyrick B
Am J Pathol; 1988 Sep; 132(3):444-54. PubMed ID: 3414777
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I and pulmonary hypertension induced by continuous air embolization in sheep.
Perkett EA; Badesch DB; Roessler MK; Stenmark KR; Meyrick B
Am J Respir Cell Mol Biol; 1992 Jan; 6(1):82-7. PubMed ID: 1728299
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte depletion attenuates sustained pulmonary hypertension and increased pulmonary vasoreactivity caused by continuous air embolization in sheep.
Perkett EA; Brigham KL; Meyrick B
Am Rev Respir Dis; 1990 Feb; 141(2):456-65. PubMed ID: 2301860
[TBL] [Abstract][Full Text] [Related]
10. Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid.
Gillissen A; Birrer P; McElvaney NG; Buhl R; Vogelmeier C; Hoyt RF; Hubbard RC; Crystal RG
J Appl Physiol (1985); 1993 Aug; 75(2):825-32. PubMed ID: 7901193
[TBL] [Abstract][Full Text] [Related]
11. Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium.
Vogelmeier C; Buhl R; Hoyt RF; Wilson E; Fells GA; Hubbard RC; Schnebli HP; Thompson RC; Crystal RG
J Appl Physiol (1985); 1990 Nov; 69(5):1843-8. PubMed ID: 2272977
[TBL] [Abstract][Full Text] [Related]
12. Lung injury and neutrophil density during air embolization in sheep after leukocyte depletion with nitrogen mustard.
Albertine KH
Am Rev Respir Dis; 1988 Dec; 138(6):1444-53. PubMed ID: 3202499
[TBL] [Abstract][Full Text] [Related]
13. Glycosaminoglycans regulate elastase inhibition by oxidized secretory leukoprotease inhibitor.
Ying QL; Kemme M; Saunders D; Simon SR
Am J Physiol; 1997 Mar; 272(3 Pt 1):L533-41. PubMed ID: 9124611
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor.
Mulligan MS; Lentsch AB; Huber-Lang M; Guo RF; Sarma V; Wright CD; Ulich TR; Ward PA
Am J Pathol; 2000 Mar; 156(3):1033-9. PubMed ID: 10702419
[TBL] [Abstract][Full Text] [Related]
16. Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity.
Vogelmeier C; Gillissen A; Buhl R
Chest; 1996 Dec; 110(6 Suppl):261S-266S. PubMed ID: 8989162
[TBL] [Abstract][Full Text] [Related]
17. Timing of corticosteroid treatment. Effect of lung lymph dynamics in air injury in awake sheep.
Jerome EH; Bonsignore MR; Albertine KH; Culver PL; Dodek PD; Perel A; Staub NC
Am Rev Respir Dis; 1990 Oct; 142(4):872-9. PubMed ID: 2221595
[TBL] [Abstract][Full Text] [Related]
18. Specific cleavage of secretory leukoprotease inhibitor by neutrophil elastase and saliva.
Masuda K; Suga T; Takeuchi A; Kanesaki M; Imaizumi A; Suzuki Y
Biochem Pharmacol; 1994 Aug; 48(4):651-7. PubMed ID: 8080437
[TBL] [Abstract][Full Text] [Related]
19. Secretory leukoprotease inhibitor: partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation.
Bingle L; Tetley TD
Thorax; 1996 Dec; 51(12):1273-4. PubMed ID: 8994529
[TBL] [Abstract][Full Text] [Related]
20. Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option?
Tomee JF; Koëter GH; Hiemstra PS; Kauffman HF
Thorax; 1998 Feb; 53(2):114-6. PubMed ID: 9624296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
